» Articles » PMID: 33104937

High-Fat Diet Induces Disruption of the Tight Junction-Mediated Paracellular Barrier in the Proximal Small Intestine Before the Onset of Type 2 Diabetes and Endotoxemia

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2020 Oct 26
PMID 33104937
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: A link between an impaired intestinal barrier, endotoxemia, and the pathogenesis of metabolic diseases, such as type 2 diabetes mellitus (T2DM), has been proposed. In previous work, we have demonstrated that the tight junction (TJ)-mediated intestinal barrier in ileum/colon was marginally changed in prediabetic mice; therefore, it does not seem to mainly contribute to the T2DM onset. In this study, the TJ-mediated epithelial barrier in the duodenum and jejunum was evaluated in mice during the development of type 2 prediabetes.

Methods/results: HF diet induced prediabetes after 60 days associated with a significant rise in intestinal permeability to the small-sized marker Lucifer yellow in these mice, with no histological signs of mucosal inflammation or rupture of the proximal intestine epithelium. As revealed by immunofluorescence, TJ proteins, such as claudins-1, -2, -3, and ZO-1, showed a significant decrease in junctional content in duodenum and jejunum epithelia, already after 15 days of treatment, suggesting a rearrangement of the TJ structure. However, no significant change in total cell content of these proteins was observed in intestinal epithelium homogenates, as assessed by immunoblotting. Despite the changes in intestinal permeability and TJ structure, the prediabetic mice showed similar LPS, zonulin, and TNF-α levels in plasma or adipose tissue, and in intestinal segments as compared to the controls.

Conclusion: Disruption of the TJ-mediated paracellular barrier in the duodenum and jejunum is an early event in prediabetes development, which occurs in the absence of detectable endotoxemia/inflammation and may contribute to the HF diet-induced increase in intestinal permeability.

Citing Articles

Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations.

Hadefi A, Leprovots M, Dinsart G, Marefati M, Vermeersch M, Monteyne D Gastro Hep Adv. 2025; 4(4):100599.

PMID: 39996241 PMC: 11849614. DOI: 10.1016/j.gastha.2024.100599.


The Role of Diet, Additives, and Antibiotics in Metabolic Endotoxemia and Chronic Diseases.

Park J, Park H, Kim Y, Park M Metabolites. 2024; 14(12).

PMID: 39728485 PMC: 11677052. DOI: 10.3390/metabo14120704.


Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet-induced obesity.

DAntongiovanni V, Fornai M, Colucci R, Nericcio A, Benvenuti L, Di Salvo C Acta Physiol (Oxf). 2024; 241(1):e14232.

PMID: 39287080 PMC: 11674374. DOI: 10.1111/apha.14232.


Sex-dependent effects of a high fat diet on metabolic disorders, intestinal barrier function and gut microbiota in mouse.

Lefebvre C, Tiffay A, Breemeersch C, Dreux V, Bole-Feysot C, Guerin C Sci Rep. 2024; 14(1):19835.

PMID: 39191839 PMC: 11349972. DOI: 10.1038/s41598-024-70931-4.


Metabolic Endotoxemia: From the Gut to Neurodegeneration.

Chmielarz M, Sobieszczanska B, Sroda-Pomianek K Int J Mol Sci. 2024; 25(13).

PMID: 39000116 PMC: 11241432. DOI: 10.3390/ijms25137006.


References
1.
Gomes J, Costa J, de Cassia Goncalves Alfenas R . Metabolic endotoxemia and diabetes mellitus: A systematic review. Metabolism. 2017; 68:133-144. DOI: 10.1016/j.metabol.2016.12.009. View

2.
Geurts L, Neyrinck A, Delzenne N, Knauf C, Cani P . Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes. 2013; 5(1):3-17. DOI: 10.3920/BM2012.0065. View

3.
Song M, Kim K, Yoon J, Kim J . Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun. 2006; 346(3):739-45. DOI: 10.1016/j.bbrc.2006.05.170. View

4.
Wellen K, Hotamisligil G . Inflammation, stress, and diabetes. J Clin Invest. 2005; 115(5):1111-9. PMC: 1087185. DOI: 10.1172/JCI25102. View

5.
Turner J . Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009; 9(11):799-809. DOI: 10.1038/nri2653. View